De Roo M - Search Results

1

Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine.

Bormans G, Cleynhens B, Adriaens P, Vanbilloen H, De Roo M, Verbruggen A. Bormans G, et al. Among authors: de roo m. Nucl Med Biol. 1995 Apr;22(3):339-49. doi: 10.1016/0969-8051(95)90920-h. Nucl Med Biol. 1995. PMID: 7627149

2

Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.

Verbruggen AM, Nosco DL, Van Nerom CG, Bormans GM, Adriaens PJ, De Roo MJ. Verbruggen AM, et al. Among authors: de roo mj. J Nucl Med. 1992 Apr;33(4):551-7. J Nucl Med. 1992. PMID: 1532419 Free article.

3

Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers.

Bormans GM, Cleynhen BJ, De Roo MJ, Verbruggen AM. Bormans GM, et al. Among authors: de roo mj. Eur J Nucl Med. 1992;19(4):271-7. doi: 10.1007/BF00175141. Eur J Nucl Med. 1992. PMID: 1534544

4

Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents.

Vanbilloen HP, Bormans GM, De Roo MJ, Verbruggen AM. Vanbilloen HP, et al. Among authors: de roo mj. Nucl Med Biol. 1995 Apr;22(3):325-38. doi: 10.1016/0969-8051(94)00110-6. Nucl Med Biol. 1995. PMID: 7627148

5

First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.

Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. Van Nerom CG, et al. Among authors: de roo mj. Eur J Nucl Med. 1993 Sep;20(9):738-46. doi: 10.1007/BF00180902. Eur J Nucl Med. 1993. PMID: 8223766

6

Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kits.

Vanbilloen HP, Verbeke KA, De Roo MJ, Verbruggen AM. Vanbilloen HP, et al. Among authors: de roo mj. Eur J Nucl Med. 1993 Jun;20(6):465-72. doi: 10.1007/BF00175158. Eur J Nucl Med. 1993. PMID: 8339729

7

Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.

Verbeke KA, Vanbilloen HP, De Roo MJ, Verbruggen AM. Verbeke KA, et al. Among authors: de roo mj. Eur J Nucl Med. 1993 Jun;20(6):473-82. doi: 10.1007/BF00175159. Eur J Nucl Med. 1993. PMID: 8339730

8

Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.

Vanbilloen HP, De Roo MJ, Verbruggen AM. Vanbilloen HP, et al. Among authors: de roo mj. Eur J Nucl Med. 1996 Jan;23(1):40-8. doi: 10.1007/BF01736988. Eur J Nucl Med. 1996. PMID: 8586100

9

Development and evaluation of a kit formulation for the preparation of 99mTc-DMP-HSA, a new tracer agent for radionuclide ventriculography.

Verbeke KA, Schiepers CW, Wyndaele DN, Baetens JA, Verbeke GN, De Roo MJ, Verbruggen AM. Verbeke KA, et al. Among authors: de roo mj. Nucl Med Biol. 1997 Aug;24(6):571-8. doi: 10.1016/s0969-8051(97)00019-x. Nucl Med Biol. 1997. PMID: 9316087

10

Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agents.

Verbeke K, Hjelstuen O, Debrock E, Cleynhens B, De Roo M, Verbruggen A. Verbeke K, et al. Among authors: de roo m. Nucl Med Commun. 1995 Nov;16(11):942-57. doi: 10.1097/00006231-199511000-00011. Nucl Med Commun. 1995. PMID: 8587761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters